$1B Sandoz Placeholder Bid Needs More Support, Judge Says

A Connecticut federal judge on Tuesday said he cannot force Novartis spinoff Sandoz Inc. to set aside a $1 billion litigation placeholder in a generic drug pricing lawsuit without hearing whether...

Already a subscriber? Click here to view full article